GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (AQSE:MYIG) » Definitions » Cyclically Adjusted PB Ratio

Mydecine Innovations Group (AQSE:MYIG) Cyclically Adjusted PB Ratio : (As of Jun. 05, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Mydecine Innovations Group Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Mydecine Innovations Group Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Mydecine Innovations Group's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mydecine Innovations Group Cyclically Adjusted PB Ratio Chart

Mydecine Innovations Group Annual Data
Trend Dec13 Aug14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Mydecine Innovations Group Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.01

Competitive Comparison of Mydecine Innovations Group's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Mydecine Innovations Group's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mydecine Innovations Group's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mydecine Innovations Group's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Mydecine Innovations Group's Cyclically Adjusted PB Ratio falls into.



Mydecine Innovations Group Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Mydecine Innovations Group's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 is calculated as:

For example, Mydecine Innovations Group's adjusted Book Value per Share data for the three months ended in Sep. 2023 was:

Adj_Book=Book Value per Share/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-0.086/125.2304*125.2304
=-0.086

Current CPI (Sep. 2023) = 125.2304.

Mydecine Innovations Group Quarterly Data

Book Value per Share CPI Adj_Book
201311 0.000 97.182 0.000
201402 0.000 98.051 0.000
201405 -0.183 99.394 -0.231
201408 -0.733 99.315 -0.924
201412 3.004 98.367 3.824
201503 0.833 99.789 1.045
201506 21.378 100.500 26.638
201509 15.774 100.421 19.671
201512 -2.721 99.947 -3.409
201603 -5.900 101.054 -7.312
201606 -7.744 102.002 -9.508
201609 -11.053 101.765 -13.602
201612 16.886 101.449 20.844
201703 16.229 102.634 19.802
201706 11.584 103.029 14.080
201709 11.687 103.345 14.162
201712 9.418 103.345 11.412
201803 16.998 105.004 20.272
201806 -4.960 105.557 -5.884
201809 15.004 105.636 17.787
201812 0.291 105.399 0.346
201903 15.800 106.979 18.496
201906 13.643 107.690 15.865
201909 21.351 107.611 24.847
201912 1.584 107.769 1.841
202003 8.570 107.927 9.944
202006 3.077 108.401 3.555
202009 1.785 108.164 2.067
202012 0.585 108.559 0.675
202103 2.363 110.298 2.683
202106 1.959 111.720 2.196
202109 0.000 112.905 0.000
202112 0.024 113.774 0.026
202203 -0.414 117.646 -0.441
202206 -0.142 120.806 -0.147
202209 -0.241 120.648 -0.250
202212 -0.146 120.964 -0.151
202303 -0.225 122.702 -0.230
202306 -0.205 124.203 -0.207
202309 -0.086 125.230 -0.086

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Mydecine Innovations Group  (AQSE:MYIG) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Mydecine Innovations Group Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Mydecine Innovations Group's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Mydecine Innovations Group (AQSE:MYIG) Business Description

Traded in Other Exchanges
Address
789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2
Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.

Mydecine Innovations Group (AQSE:MYIG) Headlines

No Headlines